Prevention of Osteoporosis in Men With Prostate Cancer

PHASE3CompletedINTERVENTIONAL

Enrollment

112

Participants

Timeline

Start Date

May 31, 2002

Study Completion Date

December 31, 2005

Conditions

Prostate CancerOsteoporosisHypogonadism

Interventions

DRUG

alendronate

Trial Locations (1)

Osteoporosis Prevention & Treatment Center, Pittsburgh

All Listed Sponsors

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00048841 - Prevention of Osteoporosis in Men With Prostate Cancer | Biotech Hunter | Biotech Hunter